Intra-cellular therapies to present at the 41st annual j.p. morgan healthcare conference

New york, jan. 03, 2023 (globe newswire) -- intra-cellular therapies, inc. (nasdaq: itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, today announced that sharon mates, ph.d., chief executive officer and chairman, is scheduled to present at the 41st annual j.p. morgan healthcare conference on monday, january 9, 2023 at 11:15 a.m. pt.
ITCI Ratings Summary
ITCI Quant Ranking